A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Condition(s) studied
Investigational drug(s) / intervention(s)
LY4005130: Administered IV
Placebo: Administered IV
Study summary
The purpose of this study is to evaluate how well LY4005130 works in participants with severe alopecia areata (hair loss) when compared with placebo, and how well it's tolerated and what side effects may occur. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.
The study drug will be administered intravenously (IV) (into a vein in the arm).
The study will last approximately 48 weeks, including screening.
Eligibility
Primary outcome measure(s)
- Percentage of Participants Achieving an Absolute Severity of Alopecia Tool (SALT) Less than or Equal to (≤) 20 — Week 24
Trial sites (30)
| Facility | City | Region | Status |
|---|---|---|---|
| Center For Dermatology Clinical Research, Inc. | Fremont | California | Recruiting |
| Northridge Clinical Trials | Northridge | California | Recruiting |
| Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway | Santa Clarita | California | Recruiting |
| Health Clinical Research, LLC | Cutler Bay | Florida | Recruiting |
| Brigham and Women's Hospital | Boston | Massachusetts | Recruiting |
| Revival Research Institute, LLC | Troy | Michigan | Recruiting |
| Stracskin | Portsmouth | New Hampshire | Recruiting |
| Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue | San Antonio | Texas | Recruiting |
| Jordan Valley Dermatology & Research Center | South Jordan | Utah | Recruiting |
| Kelowna Health and Memory Centre | Kelowna | Canada | Recruiting |
| Ryan Clinical Research Inc. | Newmarket | Canada | Recruiting |
| Dar Clinical Research - Ottawa - Hunt Club Road | Ottawa | Canada | Recruiting |
| SIMa Recherche | Verdun | Canada | Recruiting |
| Beijing Friendship Hospital Affiliate of Capital University | Beijing | China | Recruiting |
| Huashan Hospital, Fudan University | Shanghai | China | Recruiting |
| Shanghai Skin Disease Hospital | Shanghai | China | Recruiting |
| Tianjin Medical University General Hospital | Tianjin | China | Recruiting |
| Erasmus Medisch Centrum | Rotterdam | Netherlands | Recruiting |
| Centrum Badan Klinicznych PI-House sp. z o.o. | Gdansk | Poland | Recruiting |
| Diamond Clinic | Krakow | Poland | Recruiting |
| Dermedic Jacek Zdybski | Ostrowiec Świętokrzyski | Poland | Recruiting |
| Centrum Medyczne Ginemedica | Wroclaw | Poland | Recruiting |
| Chung-Ang University Hospital | Dongjak-gu | South Korea | Recruiting |
| Inha University Hospital | Incheon | South Korea | Recruiting |
| Jeonbuk National University Hospital | Jeonju | South Korea | Recruiting |
| Seoul National University Hospital | Seoul | South Korea | Recruiting |
| Kyung Hee University Hospital at Gangdong | Seoul | South Korea | Recruiting |
| Royal London Hospital | London | United Kingdom | Recruiting |
| Chelsea and Westminster Hospital NHS Foundation Trust | London | United Kingdom | Not Yet Recruiting |
| Salford Royal Hospital | Salford | United Kingdom | Recruiting |
More Eli Lilly and Company trials in the UK
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07533006 on ClinicalTrials.gov ↗ ← All trials in the UK